Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02538783 · ClinicalTrials.gov registry record · NA

The Weigh Forward, Financial Incentives for Maintenance of Weight Loss

A NA study of Obesity, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
259
Enrollment target
1
Study location

NCT02538783: Completed NA study of Obesity, sponsored by University of Pennsylvania.

NCT02538783 is a NA study of Obesity that has completed, run by University of Pennsylvania. The registered enrollment target is 259 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02538783, a NA study of Obesity, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
259 participants
Enrollment target
1
Study location

Study Summary

This study aims to evaluate the effectiveness of financial incentives in improving and maintaining weight loss.

Primary Outcome

Among participants who lost 5 kg or more of baseline weight prior to randomization, assess the effectiveness of escalating lottery rewards, relative to the control group, on maintenance of weight loss after 6 months of intervention

Conditions Studied

Interventions

  • BEHAVIORAL Escalating Lottery

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 259 participants
Start Date 2016-05-01
Est. Completion 2018-04-30
Phase NA
University of Pennsylvania

1,423 total trials

What the finished NCT02538783 record still lists

NCT02538783 is an interventional study that assigns participants to a tested intervention. The registered 259 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (68% lower).

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Escalating Lottery is the first listed.

NCT02538783 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02538783 about?

NCT02538783 is a clinical study titled "The Weigh Forward, Financial Incentives for Maintenance of Weight Loss". This study aims to evaluate the effectiveness of financial incentives in improving and maintaining weight loss.

What is the current status of trial NCT02538783?

This trial is currently completed. It is a NA study. The enrollment target is 259 participants. The study started on 2016-05-01. Estimated completion is 2018-04-30.

What conditions does trial NCT02538783 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT02538783?

The interventions under investigation include: Escalating Lottery (BEHAVIORAL).

Who is sponsoring clinical trial NCT02538783?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02538783 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02538783's enrollment target sits among peer trials

259 251st of 1053 higher than 803 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02361320 · 259 participants · NA

    Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer

  • NCT06797258 · 259 participants · NA

    FlexHD® Pliable Investigation in Implant-Based Breast Reconstruction

  • NCT06990425 · 259 participants · NA

    CLOSM Trial: Groin Closure Using Layered Option for Suture Material

  • NCT07399977 · 259 participants · NA

    Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02538783, the US trial registry maintained by the National Library of Medicine. NCT02538783 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.